Testing effectiveness (Phase 2)WithdrawnNCT00850161
What this trial is testing
Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
Who this might be right for
Type 1 Diabetes Mellitus
CPEX Pharmaceuticals Inc.